MedTrace Logo

Registration of the Study of Reyanning Mixture

NCT03704506 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2018-10-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of treating with acute tonsillitis using Reyanning mixture alone/in combination with antibiotics, and its function of reducing the use of antibiotics.

Conditions

  • Acute Tonsillitis

Interventions

DRUG

Reyanning mixture

Reyanning mixture , 20ml by mouth , 3 times per day for 7 days

DRUG

amoxil capsule

amoxil capsule , 0.5g by mouth , 3 times per day for 7 days

DRUG

Reyanning mixture simulator

Reyanning mixture simulator , 20ml by mouth , 3 times per day for 7 days

DRUG

amoxil capsule simulator

amoxil capsule simulator , 0.5g by mouth , 3 times per day for 7 days

Sponsors & Collaborators

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

    collaborator OTHER

  • Beijing Chao Yang Hospital

    collaborator OTHER

  • Wangjing Hospital, China Academy of Chinese Medical Sciences

    collaborator OTHER

  • Beijing First Hospital of integrated Chinese and Western Medicine

    collaborator OTHER

  • China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Yanming Xie, BA · Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-22
Primary Completion
2019-06-30
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03704506 on ClinicalTrials.gov